Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2006 1
2007 1
2008 3
2009 5
2010 7
2011 5
2012 5
2013 6
2014 11
2015 14
2016 14
2017 11
2018 3
2019 13
2020 10
2021 6
2022 4
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

107 results

Results by year

Filters applied: . Clear all
Page 1
Pharmacometabolomics may be the next stamp in the pharmacogenetic passport.
Klont F, Hof MAJ, Nijdam FB, Touw DJ, Bakker SJL, Hopfgartner G, Kosterink JGW, Hak E. Klont F, et al. Among authors: kosterink jgw. Pharmacol Res. 2024 Apr 26;204:107191. doi: 10.1016/j.phrs.2024.107191. Online ahead of print. Pharmacol Res. 2024. PMID: 38677531 Free article. No abstract available.
Validation of an LC-MS/MS assay for rapid and simultaneous quantification of 21 kinase inhibitors in human plasma and serum for therapeutic drug monitoring.
Al Shirity ZN, Westra N, Hateren KV, Munnink THO, Kosterink JGW, Mian P, Hooge MNL, Touw DJ, Gareb B. Al Shirity ZN, et al. Among authors: kosterink jgw. J Chromatogr B Analyt Technol Biomed Life Sci. 2023 Sep 1;1229:123872. doi: 10.1016/j.jchromb.2023.123872. Epub 2023 Sep 9. J Chromatogr B Analyt Technol Biomed Life Sci. 2023. PMID: 37716342 Free article.
Clinical Validation of a Capillary Blood Home-Based Self-Sampling Technique for Monitoring of Infliximab, Vedolizumab, and C-Reactive Protein Concentrations in Patients With Inflammatory Bowel Disease.
Otten AT, van der Meulen HH, Steenhuis M, Loeff FC, Touw DJ, Kosterink JGW, Frijlink HW, Rispens T, Dijkstra G, Visschedijk MC, Bourgonje AR. Otten AT, et al. Among authors: kosterink jgw. Inflamm Bowel Dis. 2024 Mar 1;30(3):325-335. doi: 10.1093/ibd/izad103. Inflamm Bowel Dis. 2024. PMID: 37265165 Free PMC article.
Capsules with Ileocolonic-Targeted Release of Vitamin B2, B3, and C (ColoVit) Intended for Optimization of Gut Health: Development and Validation of the Production Process.
Ahmed AA, Otten AT, Gareb B, Huijmans JE, Eissens AC, Rehman A, Dijkstra G, Kosterink JGW, Frijlink HW, Schellekens RCA. Ahmed AA, et al. Among authors: kosterink jgw. Pharmaceutics. 2023 Apr 28;15(5):1354. doi: 10.3390/pharmaceutics15051354. Pharmaceutics. 2023. PMID: 37242596 Free PMC article.
Therapeutic drug monitoring-guided treatment versus standard dosing of voriconazole for invasive aspergillosis in haematological patients: a multicentre, prospective, cluster randomised, crossover clinical trial.
Veringa A, Brüggemann RJ, Span LFR, Biemond BJ, de Boer MGJ, van den Heuvel ER, Klein SK, Kraemer D, Minnema MC, Prakken NHJ, Rijnders BJA, Swen JJ, Verweij PE, Wondergem MJ, Ypma PF, Blijlevens N, Kosterink JGW, van der Werf TS, Alffenaar JC; Voriconazole ZonMw Study Group. Veringa A, et al. Among authors: kosterink jgw. Int J Antimicrob Agents. 2023 Feb;61(2):106711. doi: 10.1016/j.ijantimicag.2023.106711. Epub 2023 Jan 13. Int J Antimicrob Agents. 2023. PMID: 36642232 Free article. Clinical Trial.
Population Pharmacokinetic Modelling and Limited Sampling Strategies for Therapeutic Drug Monitoring of Pyrazinamide in Patients with Tuberculosis.
Abolhassani-Chimeh R, Akkerman OW, Saktiawati AMI, Punt NC, Bolhuis MS, Subronto YW, Sumardi, van der Werf TS, Kosterink JGW, Alffenaar JC, Sturkenboom MGG. Abolhassani-Chimeh R, et al. Among authors: kosterink jgw. Antimicrob Agents Chemother. 2022 Jul 19;66(7):e0000322. doi: 10.1128/aac.00003-22. Epub 2022 Jun 21. Antimicrob Agents Chemother. 2022. PMID: 35727060 Free PMC article.
Association between TNF Receptors and KIM-1 with Kidney Outcomes in Early-Stage Diabetic Kidney Disease.
Waijer SW, Sen T, Arnott C, Neal B, Kosterink JGW, Mahaffey KW, Parikh CR, de Zeeuw D, Perkovic V, Neuen BL, Coca SG, Hansen MK, Gansevoort RT, Heerspink HJL. Waijer SW, et al. Among authors: kosterink jgw. Clin J Am Soc Nephrol. 2022 Feb;17(2):251-259. doi: 10.2215/CJN.08780621. Epub 2021 Dec 7. Clin J Am Soc Nephrol. 2022. PMID: 34876454 Free PMC article. Clinical Trial.
107 results